https://pmc.ncbi.nlm.nih.gov/articles/PMC3218714/
Growth hormone and tesamorelin in the management of HIV-associated lipodystrophy - PMC
HIV-infected patients on highly active antiretroviral therapy (HAART) develop a complex of body composition changes known, including peripheral fat loss...
hiv associated lipodystrophygrowth hormonein the